Literature DB >> 30892569

Prevalence Estimates for Pemphigus in the United States: A Sex- and Age-Adjusted Population Analysis.

Sara Wertenteil1, Amit Garg1, Andrew Strunk1, Allireza Alloo1.   

Abstract

Mesh：

Year:  2019        PMID： 30892569      PMCID： PMC6506879          DOI： 10.1001/jamadermatol.2018.5954

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

1.  Prevalence of pemphigus in Colombia from 2013 to 2017 according to data from the National Health Registry.

Authors:  Daniel Fernández-Avila; Laura Charry-Anzola; Lina González-Cardona
Journal:  An Bras Dermatol       Date:  2022-05-26       Impact factor: 2.113

Review 2.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

3.  Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.

Authors:  D F Murrell; A Patsatsi; P Stavropoulos; S Baum; T Zeeli; J S Kern; A-V Roussaki-Schulze; R Sinclair; I D Bassukas; D Thomas; A Neale; P Arora; F Caux; V P Werth; S G Gourlay; P Joly
Journal:  Br J Dermatol       Date:  2021-06-15       Impact factor: 9.302
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.